Heart Disease News and Research

Latest Heart Disease News and Research

Testosterone treatment in hypogonadal men may reduce cardiovascular disease risk

Research from Boston University School of Medicine suggests that testosterone treatment in hypogonadal (testosterone deficient) men restores normal lipid profiles and may reduce the risk of cardiovascular disease. These finding currently appear online in the International Journal of Clinical Practice.

24 Oct 2013

Postpartum diagnostic switches likely in depressed women

Women with major depression should be monitored for emerging symptoms of hypomania during the postpartum period, say researchers.

23 Oct 2013

UHN, Boehringer Ingelheim partner to improve care, education and support for hepatitis C patients

In a move to address a significant unmet need in hepatitis C in Canada, the University Health Network, together with Boehringer Ingelheim (Canada) Ltd., announced today a multi-year partnership that aims to improve care, education and support for patients with hepatitis C. The program, known as Link-C, aims to improve access to hepatitis C care and treatment in remote areas of Ontario and other parts of Canada.

23 Oct 2013

WHO report underlines need for quantum leap in TB care and control

Tuberculosis treatment has saved the lives of more than 22 million people, according to the WHO Global tuberculosis report 2013 published today. The report also reveals that the number of people ill with tuberculosis fell in 2012 to 8.6 million, with global TB deaths also decreasing to 1.3 million.

23 Oct 2013

Fatty acid entry into cells happens by diffusion

The current global epidemic of obesity-linked diabetes and its associated consequences -cardiovascular, neurological and renal diseases - is a growing public health problem for which therapeutic options are limited.

23 Oct 2013

FDA seeks permanent injunction against dietary supplement manufacturer James G. Cole

The U.S. Food and Drug Administration, in a complaint filed by the U.S. Department of Justice, is seeking a permanent injunction against the dietary supplement manufacturer James G. Cole, Inc., its president, James G. Cole, and its general manager, Julie D. Graves, following the company's repeated distribution of unapproved drugs and adulterated dietary supplements in violation of the Federal Food, Drug, and Cosmetic Act.

23 Oct 2013

In Calif.: Hospital laptop thefts, KP joins heart attack transfer network, substance abuse treatment expanding

Thieves steal two laptops containing patient data from an administration building of San Gabriel Valley-based AHMC Healthcare. The hospital group is uncertain if the data were accessed or used. ... The laptops were stolen Oct. 12 and contain data from patients treated at [six]AHMC hospitals (Winton, 10/21).

23 Oct 2013

Carcinogens detected in emissions downwind of 'Industrial Heartland'

Levels of contaminants higher than in some of the world's most polluted cities have been found downwind of Canada's largest oil, gas and tar sands processing zone, in a rural area where men suffer elevated rates of cancers linked to such chemicals.

23 Oct 2013

U of T researchers develop method to screen human stem cells

University of Toronto researchers have developed a method that can rapidly screen human stem cells and better control what they will turn into. The technology could have potential use in regenerative medicine and drug development. Findings are published in this week's issue of the journal Nature Methods.

23 Oct 2013

Flu vaccine may also reduce risk of heart attack by 50% among people who had heart attack

The flu vaccine may not only ward off serious complications from influenza, it may also reduce the risk of heart attack or stroke by more than 50 per cent among those who have had a heart attack, according to new research led by Dr. Jacob Udell, a cardiologist at Women's College Hospital and clinician-scientist at the University of Toronto. What's more, the vaccine's heart protective effects may be even greater among those who receive a more potent vaccine.

23 Oct 2013

Influenza vaccination linked with reduced risk of adverse cardiovascular events

Receiving an influenza vaccination was associated with a lower risk of major adverse cardiovascular events such as heart failure or hospitalization for heart attack, with the greatest treatment effect seen among patients with recent acute coronary syndrome (ACS; such as heart attack or unstable angina), according to a meta-analysis published in the October 23/30 issue of JAMA.

23 Oct 2013

STSI receives $29M grant to support innovative research on genomics, wireless technology and bioinformatics

The National Institutes of Health has renewed its prestigious Clinical and Translational Science Award (CTSA) with the Scripps Translational Science Institute (STSI) in the amount of $29 million over the next five years to support innovative research in genomics, wireless technology and bioinformatics toward individualizing medicine.

23 Oct 2013

EvergreenHealth named one of America's 100 Best Hospitals in three specialty areas

EvergreenHealth today announced it has earned several distinctions for 2014 across many of the health care system's specialties from Healthgrades, the nation's leading independent provider of information to help consumers make informed decisions about a physician or hospital.

23 Oct 2013

CoLucid signs distribution and supply agreement with ILDONG for Lasmiditan

CoLucid Pharmaceuticals, Inc., and ILDONG Pharmaceutical Co., Ltd., announced today that they have entered into a distribution and supply agreement for Lasmiditan in South Korea and Southeast Asia.

23 Oct 2013

Prompt intervention helps young bipolar patients at discharge

Young adults early in the course of bipolar disorder benefit at least as much as older patients from early intervention after hospital discharge, say researchers.

22 Oct 2013

CSI receives PMA approval to market Diamondback 360 Coronary Orbital Atherectomy System

Cardiovascular Systems, Inc., today announced that it has received PMA approval from the U.S. Food and Drug Administration to market its Diamondback 360® Coronary Orbital Atherectomy System (OAS) as a treatment for severely calcified coronary arteries.

22 Oct 2013

diaDexus amends agreement with Comerica Bank to expand existing loan facility

diaDexus, Inc., a company developing and commercializing proprietary cardiovascular diagnostic products, today announced that it has amended its agreement with Comerica Bank to expand its existing loan facility from $5 million to $10 million.

22 Oct 2013

First Edition: October 22, 2013

Today's headlines include reports about the Obama administration's plans to address the problems with healthcare.gov.

22 Oct 2013

RMA of New York partners with Mount Sinai Medical Center to study long-term effects of PCOS

Reproductive Medicine Associates of New York is proud to announce their partnership with Mount Sinai Medical Center on a study that will examine the long-term effects of PCOS on children born to mothers who have been diagnosed with this condition.

22 Oct 2013

Researchers lead project to build first medical surveillance bracelet for senior citizens

Researchers form the Institute of Nuclear Sciences (ICN) at the Mexican National Autonomous University (UNAM) lead a project conceived and entrusted by the Mexican Enterprise Matersys Group, to build the first medical surveillance bracelet for senior citizens.

22 Oct 2013

Heart Disease News and Research

Latest Heart Disease News and Research

Testosterone treatment in hypogonadal men may reduce cardiovascular disease risk

Postpartum diagnostic switches likely in depressed women

UHN, Boehringer Ingelheim partner to improve care, education and support for hepatitis C patients

WHO report underlines need for quantum leap in TB care and control

Fatty acid entry into cells happens by diffusion

FDA seeks permanent injunction against dietary supplement manufacturer James G. Cole

In Calif.: Hospital laptop thefts, KP joins heart attack transfer network, substance abuse treatment expanding

Carcinogens detected in emissions downwind of 'Industrial Heartland'

U of T researchers develop method to screen human stem cells

Flu vaccine may also reduce risk of heart attack by 50% among people who had heart attack

Influenza vaccination linked with reduced risk of adverse cardiovascular events

STSI receives $29M grant to support innovative research on genomics, wireless technology and bioinformatics

EvergreenHealth named one of America's 100 Best Hospitals in three specialty areas

CoLucid signs distribution and supply agreement with ILDONG for Lasmiditan

Prompt intervention helps young bipolar patients at discharge

CSI receives PMA approval to market Diamondback 360 Coronary Orbital Atherectomy System

diaDexus amends agreement with Comerica Bank to expand existing loan facility

First Edition: October 22, 2013

RMA of New York partners with Mount Sinai Medical Center to study long-term effects of PCOS

Researchers lead project to build first medical surveillance bracelet for senior citizens

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Heart Disease News and Research

Latest Heart Disease News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in